MIR6856

Across TCGA pan-cancer cohorts, MIR6856 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR6856 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR6856 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6856 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

THCA, DLBC, and KIRC are the cancer types where MIR6856 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.844	0.957	<.001	99	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
KIRC	DFS	Tertile	IV	0.136	0.358	.006	36	view →
HNSC	DFS	Tertile	IV	0.709	0.378	.018	30	view →
PRAD	DFS	Tertile	All	0.551	0.789	.001	24	view →
READ	DFS	Tertile	IV	0.082	0.619	.001	18	view →
OV	OS	Tertile	IV	0.301	0.639	.026	18	view →
LIHC	DFS	Tertile	All	0.245	0.453	.029	15	view →
ESCA	OS	Quartile	III,IV	0.258	0.485	.021	6	view →
SKCM	OS	Tertile	II,III,IV	0.737	0.846	.033	3	view →
COAD	OS	Tertile	II,III,IV	0.697	0.862	.017	3	view →
LGG	DFS	Tertile	All	0.606	0.771	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR6856–THCA (OS)

Open the THCA breakdown →